Serum metabolomic response of myasthenia gravis patients to chronic prednisone treatment.

Serum metabolomic response of myasthenia gravis patients to chronic prednisone treatment.

Prednisone is often used for the treatment of autoimmune and inflammatory diseases but they suffer from variable therapeutic responses and significant adverse effects. Serum biological markers that are modulated by chronic corticosteroid use have not been identified. Myasthenia gravis is an autoimmu...

Full description

Bibliographic Details
Main Authors: Manjistha Sengupta, Amrita Cheema, Henry J Kaminski, Linda L Kusner, Muscle Study Group
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2014-01-01
Series:PLoS ONE
Online Access:http://europepmc.org/articles/PMC4102553?pdf=render

Similar Items

Similar Items